213 related articles for article (PubMed ID: 20737634)
1. Bilayered nail lacquer of terbinafine hydrochloride for treatment of onychomycosis.
Shivakumar HN; Vaka SR; Madhav NV; Chandra H; Murthy SN
J Pharm Sci; 2010 Oct; 99(10):4267-76. PubMed ID: 20737634
[TBL] [Abstract][Full Text] [Related]
2. Permeation studies of novel terbinafine formulations containing hydrophobins through human nails in vitro.
Vejnovic I; Huonder C; Betz G
Int J Pharm; 2010 Sep; 397(1-2):67-76. PubMed ID: 20620203
[TBL] [Abstract][Full Text] [Related]
3. New Polyurethane Nail Lacquers for the Delivery of Terbinafine: Formulation and Antifungal Activity Evaluation.
Gregorí Valdes BS; Serro AP; Gordo PM; Silva A; Gonçalves L; Salgado A; Marto J; Baltazar D; Dos Santos RG; Bordado JM; Ribeiro HM
J Pharm Sci; 2017 Jun; 106(6):1570-1577. PubMed ID: 28263845
[TBL] [Abstract][Full Text] [Related]
4. Enhanced Ungual Permeation of Terbinafine HCl Delivered Through Liposome-Loaded Nail Lacquer Formulation Optimized by QbD Approach.
Shah VH; Jobanputra A
AAPS PharmSciTech; 2018 Jan; 19(1):213-224. PubMed ID: 28681334
[TBL] [Abstract][Full Text] [Related]
5. Terbinafine hydrochloride loaded liposome film formulation for treatment of onychomycosis: in vitro and in vivo evaluation.
Tanrıverdi ST; Hilmioğlu Polat S; Yeşim Metin D; Kandiloğlu G; Özer Ö
J Liposome Res; 2016; 26(2):163-73. PubMed ID: 26226352
[TBL] [Abstract][Full Text] [Related]
6. A multicentre, randomized, controlled study of the efficacy, safety and cost-effectiveness of a combination therapy with amorolfine nail lacquer and oral terbinafine compared with oral terbinafine alone for the treatment of onychomycosis with matrix involvement.
Baran R; Sigurgeirsson B; de Berker D; Kaufmann R; Lecha M; Faergemann J; Kerrouche N; Sidou F
Br J Dermatol; 2007 Jul; 157(1):149-57. PubMed ID: 17553051
[TBL] [Abstract][Full Text] [Related]
7. Hydrosoluble medicated nail lacquers: in vitro drug permeation and corresponding antimycotic activity.
Monti D; Saccomani L; Chetoni P; Burgalassi S; Senesi S; Ghelardi E; Mailland F
Br J Dermatol; 2010 Feb; 162(2):311-7. PubMed ID: 19886884
[TBL] [Abstract][Full Text] [Related]
8. Ungual and trans-ungual iontophoretic delivery of terbinafine for the treatment of onychomycosis.
Nair AB; Kim HD; Chakraborty B; Singh J; Zaman M; Gupta A; Friden PM; Murthy SN
J Pharm Sci; 2009 Nov; 98(11):4130-40. PubMed ID: 19340887
[TBL] [Abstract][Full Text] [Related]
9. Optimized Ciclopirox-Based Eudragit RLPO Nail Lacquer: Effect of Endopeptidase Enzyme as Permeation Enhancer on Transungual Drug Delivery and Efficiency Against Onychomycosis.
Khattab A; Shalaby S
AAPS PharmSciTech; 2018 Apr; 19(3):1048-1060. PubMed ID: 29138987
[TBL] [Abstract][Full Text] [Related]
10. Formulation development and optimization of transungual drug delivery system of terbinafine hydrochloride for the treatment of onychomycosis.
Patel MM; Vora ZM
Drug Deliv Transl Res; 2016 Jun; 6(3):263-75. PubMed ID: 26926242
[TBL] [Abstract][Full Text] [Related]
11. A study on the effect of inorganic salts in transungual drug delivery of terbinafine.
Nair AB; Sammeta SM; Vaka SR; Narasimha Murthy S
J Pharm Pharmacol; 2009 Apr; 61(4):431-7. PubMed ID: 19298688
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of amorolfine nail lacquer for the prophylaxis of onychomycosis over 3 years.
Sigurgeirsson B; Olafsson JH; Steinsson JT; Kerrouche N; Sidou F
J Eur Acad Dermatol Venereol; 2010 Aug; 24(8):910-5. PubMed ID: 20028447
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and tolerability of amorolfine 5% nail lacquer in combination with systemic antifungal agents for onychomycosis: A meta-analysis and systematic review.
Feng X; Xiong X; Ran Y
Dermatol Ther; 2017 May; 30(3):. PubMed ID: 28097731
[TBL] [Abstract][Full Text] [Related]
14. Determination of terbinafine in nail samples during systemic treatment for onychomycoses.
Dykes PJ; Thomas R; Finlay AY
Br J Dermatol; 1990 Oct; 123(4):481-6. PubMed ID: 2151303
[TBL] [Abstract][Full Text] [Related]
15. A randomized comparison of nail surface remanence of three nail lacquers, containing amorolfine 5%, ciclopirox 8% or tioconazole 28%, in healthy volunteers.
Sidou F; Soto P
Int J Tissue React; 2004; 26(1-2):17-24. PubMed ID: 15573688
[TBL] [Abstract][Full Text] [Related]
16. Terbinafine hydrochloride nail lacquer for the management of onychomycosis: formulation, characterization and in vitro evaluation.
Thatai P; Sapra B
Ther Deliv; 2018 Feb; 9(2):99-119. PubMed ID: 29325509
[TBL] [Abstract][Full Text] [Related]
17. Single-blind, randomized, prospective study on terbinafine and itraconazole for treatment of dermatophyte toenail onychomycosis in the elderly.
Gupta AK; Konnikov N; Lynde CW
J Am Acad Dermatol; 2001 Mar; 44(3):479-84. PubMed ID: 11209118
[TBL] [Abstract][Full Text] [Related]
18. Development of ciclopirox nail lacquer with enhanced permeation and retention.
Thapa RK; Choi JY; Go TG; Kang MH; Han SD; Jun JH; Son MW; Yong CS; Kim JO
Arch Pharm Res; 2016 Jul; 39(7):953-9. PubMed ID: 27306785
[TBL] [Abstract][Full Text] [Related]
19. Transungual delivery of terbinafine by iontophoresis in onychomycotic nails.
Nair AB; Vaka SR; Murthy SN
Drug Dev Ind Pharm; 2011 Oct; 37(10):1253-8. PubMed ID: 21457120
[TBL] [Abstract][Full Text] [Related]
20. An investigation of how fungal infection influences drug penetration through onychomycosis patient's nail plates.
McAuley WJ; Jones SA; Traynor MJ; Guesné S; Murdan S; Brown MB
Eur J Pharm Biopharm; 2016 May; 102():178-84. PubMed ID: 26969264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
